Dr. Razan Mohty, MD

Dr. Mohty practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dr. Mohty's NPI, 1972170454, was assigned on June 4, 2021. Dr. Mohty holds Florida license TRN33630.

Dr. Mohty's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Dr. Mohty's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Mohty is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Dr. Mohty to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mohty practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mohty's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Mohty is licensed in Florida.

CMS data shows 144 Medicare services from Dr. Mohty across 1 procedure code in 2024, for 42 Medicare patients. Medicare paid $12,478 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Dr. Mohty in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mohty's median patient age at 65, with 45% women.

In 2024, Dr. Mohty wrote 307 Medicare Part D claims for 65 patients. 78% of them were for generic drugs. CMS names the drug for 140 of them, across 6 drugs with 11 or more claims each, at $31,833 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Mohty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mohty as offering telehealth.

Dmand AI links 47 papers to Dr. Mohty, published from 2018 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Hematopoietic Stem Cell Transplantation, Immunotherapy, Adoptive and Receptors, Chimeric Antigen. Dr. Mohty has published most often in Bone Marrow Transplant. Dr. Mohty's most frequent co-authors are Yi Lin, MD, Hemant Sreenivasa Murthy, MD and Hassan B. Alkhateeb, MD.

CMS Open Payments shows 7 general payments to Dr. Mohty from 6 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Kite Pharma, Inc. paid the most, $257.